At The Jackson Laboratory, collaboration is how we solve problems that are too complex for any one lab or institution. We bring together the right people, expertise, and resources to accelerate discovery, translate research into better patient outcomes, and improve human health.
Connecting research, genomics, and patient care to improve health outcomes.
The Maine Cancer Genomics Initiative (MCGI) is an alliance of Maine oncology providers led by The Jackson Laboratory with funding from the Harold Alfond™ Foundation. Its primary goal is to reduce disparities in access to advanced technologies for cancer care and precision medicine.
The JAX Advanced Precision Medicine Laboratory (APML) provides precise genomic solutions to enhance personalized care in disease treatment.
View more
Collaboration advances next-generation, human-relevant research tools to accelerate the development of treatments for Alzheimer’s disease and other neurodegenerative conditions
View more
With more than 60 successful collaborations, JAX’s Rare Disease Translational Center (RDTC) is a vital research hub for the rare disease community.
View moreLearn more about clinical collaborations
Working alongside leading academic institutions, industry, and nonprofit organizations to accelerate discovery.
Endometriosis research at JAX is improving the lives of those impacted by the disease – from seeking to develop early detection with genetic testing to understanding the development of the condition at a single cell level.
View moreLearn more about research partnerships
Collaboration has been a major pat of JAX’s culture since its founding in 1929. Today, At It remains a vital part of our mission to empower the global biomedical community with the expertise, tools, data and resources that accelerate understanding and advance treatments.